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Abstract: Aging is a multifactorial and tissue-specific process involving diverse alterations regarded
as the “hallmarks of aging”, which include genomic instability, telomere attrition, epigenetic
alterations, loss of proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular
senescence, stem cell exhaustion and altered intracellular communication. Virtually all these hallmarks
are targeted by dietary olive oil, particularly by virgin olive oil, since many of its beneficial effects can
be accounted not only for the monounsaturated nature of its predominant fatty acid (oleic acid), but
also for the bioactivity of its minor compounds, which can act on cells though both direct and indirect
mechanisms due to their ability to modulate gene expression. Among the minor constituents of virgin
olive oil, secoiridoids stand out for their capacity to modulate many pathways that are relevant for
the aging process. Attenuation of aging-related alterations by olive oil or its minor compounds has
been observed in cellular, animal and human models. How olive oil targets the hallmarks of aging
could explain the improvement of health, reduced risk of aging-associated diseases, and increased
longevity which have been associated with consumption of a typical Mediterranean diet containing
this edible oil as the predominant fat source.
Keywords: DNA damage; fatty acids; hallmarks of aging; Mediterranean diet; olive oil; oxidative
stress; polyphenols; senescence
1. Introduction
Aging is a time-dependent progressive decline in physiological function of the organism that takes
place with decreased fertility and increased susceptibility to endogenous and external threats, leading
to a wide variety of related diseases such as degenerative and neoplastic disorders. Nowadays, it has
been recognized that aging-related alterations are multifactorial and tissue-specific at the organismal
level, and involve diverse processes regarded as the “hallmarks of aging”. These hallmarks include
genomic instability, telomere attrition, epigenetic alterations, loss of proteostasis, deregulated nutrient
sensing, mitochondrial dysfunction, cellular senescence, stem cell exhaustion and altered intracellular
communication [1]. Scientists have demonstrated a strong interest not only in unravelling the causes
of aging, but also in discovering how we can manipulate potential causes of aging to decrease, stop,
or even revert its rate of progression [2,3]. Of note, a number of dietary approaches have revealed
successful to decrease the incidence of aging-related diseases or to even increase lifespan.
Pro-survival properties of antioxidants have been shown in several disease models [4], although
only a few interventions with antioxidants have successfully increased lifespan so far [5]. Calorie
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restriction without malnutrition is clearly the best characterized non-genetic intervention that increases
maximum lifespan and improves healthspan, preventing or delaying the onset of pathophysiological
changes in multiple species [6]. In addition, prospective studies have shown that adherence to a typical
Mediterranean diet with olive oil (OO) as the predominant fat source is associated with improved
health, lower mortality and increased longevity, reduced risk of cardiovascular diseases, cancer, and
the incidence of age-related cognitive decline as Parkinson’s and Alzheimer’s disease [7]. These
benefits have been attributed not only to its high monounsaturated fatty acid (MUFA) content but
also to the healthy properties of minor though highly bioactive components, particularly in the case
of virgin (VOO) and extra virgin olive oil (EVOO). These minor components can be classified into
the unsaponifiable (non-polar) and the soluble (polar) fraction, which includes a variety of phenolic
compounds such as hydroxytyrosol (HT), tyrosol, caffeic acid, oleuropein aglycone, and oleocanthal,
among others [7,8]. Besides these prospective studies carried out with human populations, animal
studies have also indicated that OO phenols have preventive actions on age-related cognitive and motor
dysfunction. Furthermore, mechanistic in vitro studies also indicate that OO phenolic compounds may
inhibit inflammatory pathways, induce signaling pathways related to cell protection and survival, and
modulate pathways related to energy metabolism similar to anti-aging substances, which has been
summarized in an excellent review [9]. The present review not only constitutes an update including
the most recent advances on the research liking OO and the prevention of aging-related alterations, but
also it is focused on the systematic evaluation of how OO and its minor constituents act on the recently
recognized hallmarks of aging. Elucidating how OO targets these hallmarks can help us to better
understand the molecular and cellular basis of its beneficial action on aging and aging-related diseases.
Moreover, for our review we will consider not only OO (in its varieties) and the compounds contained
in this edible oil at a pharmacologically relevant concentration, but also olive-related compounds
that can be used as purified molecules or as extracts obtained from sources as olives and olive leafs,
among others. These substances have been used for a significant part of the research aimed on giving
a mechanistic explanation of how OO exerts its positive effects on cellular pathways that are altered
with aging, and they can set up the basis for designing future olive-derived functional foods which
positively impact human aging.
2. Olive Oil and Genomic Instability
The genetic material tends to accumulate damage during aging because it is continuously
challenged by exogenous and endogenous threats [1]. In an aging context, oxidative damage to
mitochondrial DNA (mtDNA) is more important than the damage exerted to lipids and proteins due
to the ability of mtDNA to be disseminated in the division of mitochondria and cells, which amplifies
the physiological consequences of the damage [10]. Traditionally, mtDNA has been considered
highly susceptible to oxidative attack because: (i) the mitochondrial respiratory chain is a source of a
continuing flux of oxygen radicals; (ii) it is not protected by histones; and (iii) the mitochondria may be
less efficient in repairing DNA damage and replication errors than the nucleus [11]. In addition, aging
is associated with deletions of mtDNA in a tissue-dependent manner [12], affecting mainly postmitotic
tissues like the brain, skeletal muscle and heart [13]. Some studies indicate that multiple mtDNA
deletions may be promoted by double strand breaks [14].
Several studies have tried to test the effect of OO avoiding the age-associated damage in the
DNA, both in vivo and in vitro. Quiles et al. have tested the effects of feeding male Wistar rats with
diets containing different fat sources as VOO and sunflower oil (SO) [15]. Lower levels of DNA
double-strand breaks in peripheral blood lymphocytes were found in young animals fed on VOO,
which reached around one half of the damage that was found in the SO group. The same measurements
were carried out in aged rats showing that, although the aging-related increase of DNA double-strand
breaks levels that took place in both dietary groups, the damage was significantly lower in rats fed a
diet containing VOO. However, the two groups did not differ in either mean or maximum life span.
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Another study from the same research group was set to analyze the presence of a particular
deletion in liver of rats fed diets containing VOO or SO [16]. Two regions of the mitochondrial
genome were studied: ND1 and ND4 genes. The former is rarely affected by deletions in humans
and rats whereas the latter is included in the so-called common deletion both in humans and rats.
While an increase of more than 6-fold in the deletion was found in the case of old animals fed the
VOO-containing diet, the increase was 60% higher (more than 10-fold) in old animals fed the diet
containing SO. These observations support that dietary fat type can modulate the frequency of the
studied deletion in rat liver and that the age-related increase in mtDNA deletions could be attenuated.
The lower increase in mtDNA deletion frequency during aging was attributed to the lower amount of
free radicals produced by VOO.
Fabiani et al. have measured the effect of OO phenolics on H2O2-induced DNA damage in human
peripheral blood mononuclear cells (PBMC) and promyelocytic leukemia cells (HL-60) [17]. Their
results showed that HT, a complex olive oil phenol extract (OOPE), and olive mill wastewater phenol
extract (WW-PE) displayed a highly protective activity against DNA damage in both PBMC and HL-60
cells. Furthermore, other purified compounds like one isomer of oleuropein aglycon, oleuropein,
tyrosol, caffeic acid and verbascoside also displayed a protective effect on cells although in a lower
range. These results suggest that phenols used at low concentrations (1–10 mmol/L), as purified
compounds or in a complex crude extract independently of the source (OO or WW-PE), may prevent
DNA damage induced by H2O2. These concentrations could be easily reached in the tissues with an
ordinary intake of 50 g/day of olive oil, because these phenolic compounds are effectively absorbed in
humans [18].
Additional studies have demonstrated that pretreatment of Hela cells with OOPE also prevents
nDNA damage induced by H2O2 [19]. This protection might be associated with OOPE’s free radical
scavenging properties, metal ion chelating properties and/or the endogenous antioxidant defenses
and DNA repair systems [17]. In addition, VOO phenolics could protect APEX1, a DNA repair gene,
by inhibition of oxidative nDNA damage [19].
3. Olive Oil Effect on Telomere Attrition
Telomeres are nucleoprotein structures that protect the ends of eukaryote chromosomes [20].
Importantly, telomere shortening is also observed during normal aging both in human and in mice [21].
Telomere length is considered to be a biomarker of aging; shorter telomeres are associated with a
decreased life expectancy and increased rates of developing age related chronic diseases [22–24].
However, telomere length varies considerably among individuals [25]. DNA in these structures is
particularly susceptible to age-related deterioration [26]. One of the reasons for this is that replicative
DNA polymerases lack the capacity to replicate completely the terminal ends of linear DNA molecules,
a function that is proprietary of a specialized DNA polymerase known as telomerase. However, most
mammalian somatic cells do not express telomerase, and this leads to the progressive and cumulative
loss of telomere-protective sequences from chromosome ends [1]. Moreover, telomeres are bound by
a characteristic multiprotein complex known as shelterin [27] that prevent the access of DNA repair
proteins to the telomeres. Although telomere length is strongly influenced by genetic factors, telomere
attrition might be modulated by environmental and lifestyle factors, including older age, cigarette
smoking, gender, ethnicity [28], education [29] and other indicators of socioeconomic status [30] and
diet [31]. Studies have suggested that telomere attrition is modifiable, as substantial variability exists in
the rate of telomere shortening that is independent of chronological age [32–34]. Therefore, variability
of telomere length may be partially explained by lifestyle practices, including dietary patterns.
Some reports have indicated a positive relationship of leukocyte telomere length and
Mediterrranean diet adherence in two different human population subsets [35,36]. These included
a cohort of elderly subjects from the South Italy [35] and a group of nurses aged 30–55 years [35].
Similarly, a study comparing between Greek and Dutch elderly men has reported that the latter
presented lower leukocyte telomere length [37]. When measured, telomerase activity has also shown a
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positive association that correlates with leukocyte telomere length [35]. Oxidative stress may influence
the rate of telomeres shortening [37]. In that sense, it has been reported that telomerase activity was
negatively modulated by inflammation and oxidative stress [35]. In contrast, no relationship between
leukocyte telomere length and indicators of oxidative stress and plasma antioxidants was found in
the study comparing Dutch and Greek elderly men, although the endogenous serum antioxidants
albumin and uric acid were positively associated with telomere length [37].
Studies directly evaluating the effects of OO intake on leukocyte telomere length are absent.
Of note, regression analysis showed that the Mediterranean diet adherence was not associated with
leukocyte telomere length in the overall study population after adjusting for age, sex, education,
ethnicity, caloric intake, smoking, and physical and leisure activities. However, a significant association
with leukocyte telomere length was recognized among non-Hispanic whites. Furthermore, it was
found that higher adherence to a Mediterranean diet was associated with longer leukocyte telomere
length among whites, but not among African Americans and Hispanics [38]. Thus, results may not be
generalized to other populations.
Another intervention has been performed on elderly subjects that consumed three diets, each
for four weeks: a saturated fatty acid (SFA) diet, a low-fat and high-carbohydrate diet, and a
Mediterrranean diet enriched in MUFA following a randomized crossover design. Human umbilical
endothelial cells were incubated with serum from each patient. Among these, the MUFA-rich diet
induced lower percentage of cells with telomere shortening, compared with the baseline and the other
two diets. Moreover, this effect correlated with lower intracellular production of reactive oxygen
species (ROS) and diminished cellular apoptosis [39].
The Prevención con Dieta Mediterránea (PREDIMED) trial consists in a 5-year nutritional
intervention with three groups: Mediterranean diet specifically supplemented with EVOO,
Mediterranean diet supplemented with mixed nuts, or a low-fat diet as control group. In a subset
from this study, higher baseline telomere length significantly predicted a greater decrease in body
weight body mass index (BMI), waist circumference and waist to height ratio. In addition, changes
in telomere length during the 5-year intervention were inversely associated with changes in the
four anthropometric variables. The reduction in adiposity indices during the intervention that was
associated with increased telomere length was even higher among subjects with the longest telomeres
at baseline. Logistic regression analysis showed that the risk of remaining obese after 5 years was
lower in those participants who initially had the longest telomeres and increased their telomere length
after intervention [40].
Telomerase itself could be a potential target to prevent telomere length attrition. Actually,
telomerase deficiency in humans has associated with premature development of diseases, such
as pulmonary fibrosis, dyskeratosis congenita, and aplastic anemia, which involve the loss of the
regenerative capacity of different tissues [41]. Two phenolic compounds, oleacein and oleuropein,
mainly present in olive leaves, seem interesting at this respect according to the results obtained in
an in vitro assay. Namely, exposition of endothelial progenitor cells to any of these compounds prior
to angiotensin II treatment increased telomerase activity. This effect was also associated with an
increase of proliferation and a decrease in the percentage of senescent cells and intracellular ROS
formation [42], as described in the “Stem Cell Exhaustion” section. However, it has to be taken into
account that the amount of oleuropein in EVOO is very low. Furthermore, whether OO intake may
affect telomerase activity is still poorly investigated and no in vivo effects have been reported, which
warrants future research.
4. Epigenetic Changes Induced by Olive Oil
Epigenetic modifications are heritable changes in gene function that are not caused by
variation in DNA sequence [43]. These changes mainly involve alterations in DNA methylation
patterns, posttranslational modification of histones, and chromatin remodeling. There are multiple
enzymatic systems assuring the generation and maintenance of epigenetic patterns, including DNA
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methyltransferases, histone acetylases, deacetylases, methylases, and demethylases, as well as protein
complexes implicated in chromatin remodeling. Aging-associated transcriptional signatures also affect
noncoding RNAs, including microRNAs (miRNAs) [1]. Epigenetic processes are dynamic and may be
affected by environmental factors such as exercise and diet [44,45]. Actually, diet is the more studied
environmental factor in epigenetics [46].
One of the most common epigenetic marks is DNA methylation. DNA methylation may play an
important role in causing disease by silencing genes through hypermethylation or activating genes
through hypomethylation. Cytosine DNA methylation, the most studied epigenetic mechanism,
is usually considered as a flexible method for repressing gene expression. Different dietary and
lifestyle factors are able to modulate the methylation of specific CpG sites in gene promoters even in
the adult age [45]. Changes have been observed in DNA methylation patterns during aging [47,48],
although hypermethylation has been noted in some loci while hypomethylation has been also noted in
others [49].
In relation to OO, an observational study performed on Greek adolescents has been recently
published with very interesting results. A genome-wide methylation profile in blood revealed that
the MUFA to SFA ratio in the diet was associated with 26 island shores and 158 site [50]. This dietary
feature is typical of Mediterranean diets, likely due to the high intake of OO [51]. In that sense, dietary
interventions with Mediterranean diets have also shown that DNA methylation levels were associated
with adherence to the diet [52]. According to previous findings, it is possible that OO was able to
induce epigenetic changes by means of its MUFA content. However, an in vitro study carried out
with human colon cancer cells (Caco-2) has reported very similar effects for VOO and its phenolic
compounds [46].
Along with DNA methylations, EVOO could also induce epigenetic changes by histone acetylation
processes. In support of this, an in vitro assay has shown that some phenolic compounds contained
in EVOO, namely secoiridoids (i.e., oleuropein and its conjugated forms), are able to induce
hyperacetylation of histone H3 in cell cultures, among many other effects [53].
Another point of interest is the possible genes affected by methylation and their implications
for aging process. All the epigenetic changes derived from OO or its minor compounds have been
usually studied only in specific genes, and several of these genes have shown relationship with the
aging process. In particular, many of them have been related with susceptibility to aging-related
diseases such as metabolic syndrome. In relation to this, some intervention studies have indicated that
OO or Mediterranean diets influence DNA methylation in genes encoding enzymes involved in fatty
acid metabolism. In renal patients, OO supplements altered methylation of fatty acid desaturase
(FADS)-2 CpGs and elongase (ELOVL)-5 CpGs. The methylation status of the altered CpGs in
FADS2 and ELOVL5 was associated negatively with the level of their transcripts [54]. Similarly,
in a dietary intervention study with Mediterranean diet to decrease weight of the subjects, those who
lost weight showed higher levels of stearoyl CoA desaturase (SCD)-1 gene promoter methylation
after one year. Furthermore, these subjects presented higher adherence to a Mediterranean diet [52].
Previously, it was reported that variations in SCD activity were associated with disorders such as
obesity, insulin resistance, and diabetes [55,56], which suggests that gene expression modifications
can affect metabolic syndrome onset and progression. In addition, it has been reported that SCD1
knockdown increased the amount of SFA and decreased that of MUFA in HeLa cells membrane
phospholipids without affecting the amount or the composition of free fatty acids [57]. The degree
of fatty acid unsaturation in membrane phospholipids affects many membrane-associated functions
which highlights the importance of SCD1. In particular, OO intake increases membrane MUFA
content [58], which could be accounted not only by its high-MUFA content but also by its effect on
SCD1 gene, reinforcing the notion that Mediterranean diet effect on SCD1 may be a consequence
of OO.
Other genes interesting in relation to metabolic syndrome are those involved in circadian rhythms.
In women, it has been reported that the percentage of methylation of the clock circadian regulator gene
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(CLOCK) CLOCK CpGs 1 and 8 showed associations with the intake of MUFA and polyunsaturated
fatty acids (PUFA) [59]. The circadian clock system instructs 24 h rhythmicity on gene expression
in essentially all cells [59] and it has been related to obesity and metabolic syndrome features.
It has been reported that patients with visceral obesity and metabolic syndrome exhibit disturbances
in the circadian rhythm (chronodisruption) that may be associated with higher weight increase and
development of diabetes and atherosclerotic disease [60,61]. This is in accordance with findings from
the same study since a different pattern of DNA methylation of CLOCK and BMAL1 gene between
normal-weight and overweight or obese subjects was noted. Moreover, the methylation pattern of
different CpG sites of the three genes showed significant associations with anthropometric parameters
such as body mass index and adiposity, and with a metabolic syndrome score [59].
On the other hand, an in vitro study with Caco-2 cells has also shown possible anticancer effects
for EVOO by means of this mechanism, since it influenced DNA methylation state at CNR1 promoter
which was inversely correlated to selective and transient up-regulation of CNR1 gene, a tumor
suppressor that encodes for type 1 cannabinoid receptor (CB1). EVOO, a phenolic EVOO extract or HT
stimulated CB1 expression which was associated with reduced proliferation of these cancer cells [46].
The same authors confirmed this anticancer effect in rats where dietary EVOO supplementation
increased CB1 mRNA. Consistently, CpG methylation of rat Cnr1 promoter, miR23a and miR-301a,
previously shown to be involved in the pathogenesis of colorectal cancer [62] and predicted to
target CB1 mRNA, were reduced after administration of EVOO down to ~50% of controls [46].
In another in vitro study, EVOO phenolic extracts rich in secoiridoids permitted Histone H3 remain
in hyperacetylated state at Hysine 18 in a breast cancer model (the HER2-gene amplified JIMT-1 cell
line, a unique breast cancer model). The resulting alterations in gene regulation could reduce mitotic
viability and metabolic competence of breast cancer cells, inherently refractory to HER-targeting
therapies ab initio [53].
miRNAs are small endogenous non-coding RNAs that regulate several cellular and biologic
processes by regulating gene expression [63] that may epigenetically explain the long-term phenotypic
changes of the offspring. Some researchers have also studied this mechanism deepened in. In rats,
it has been reported that maternal consumption of different types of fat sources, including OO, during
early pregnancy influenced miRNAs expression in both maternal and offspring tissues [64]. The
influence of dietary fat on miRNAs has also been reported in humans. In the PREDIMED randomized
trial, a novel association between a microRNA target site variant and stroke incidence was reported
which is modulated by diet in terms of decreasing triglycerides and possibly stroke risk in rs13702C
allele carriers after a highly-unsaturated fat Mediterranean diet intervention [65].
5. Olive Oil Effects on Proteostasis
A multitude of quality control mechanisms have evolved to preserve the stability and functionality
of proteomes in cells. These mechanisms function in a coordinated fashion to restore the structure of
misfolded polypeptides or to remove and degrade them completely, thus preventing the accumulation
of damaged components and assuring the continuous renewal of intracellular proteins [1]. Protein
homeostasis or proteostasis involves both mechanisms for the stabilization of correctly folded proteins
(i.e., the heat shock family of proteins) and mechanisms for the degradation of proteins (i.e., the
ubiquitin-proteasome system and those including lysosomes) [66–68]. The heat shock family of
proteins includes several isoforms of 70-kDa heat shock proteins (Hsp70) that can be constitutively
expressed and stress-induced as well. They are chaperones involved in crucial cellular functions [69–72].
While constitutively expressed Hsp70 chaperones have housekeeping functions (e.g., folding of nascent
polypeptides, protein translocation between cellular compartments and degradation of unstable and
misfolded proteins), stress-induced Hsp70s prevent the accumulation of proteins that have become
denatured in response to various cellular stresses (e.g., heat stress, radiation, ischemia, heavy metals
or other stimuli that activate stress transcription factors). Stress-induced synthesis of cytosolic and
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organelle-specific chaperones is significantly impaired in aging [73] and research with animal models
supports the positive impact of chaperones on longevity [74–77].
Aging and some aging-related diseases are associated with perturbed proteostasis, and its
experimental perturbation can precipitate age-associated pathologies [1,67,78]. This is particularly
notably in some age-related pathologies, such as Alzheimer’s disease, Parkinson’s disease, and
cataracts where chronic expression of unfolded, misfolded, or aggregated proteins contributes to
their development [78]. Different in vitro studies have shown interesting activities of olive phenolic
compounds on protein aggregates of this type. HT, oleuropein, and oleuropein aglycone prevented
Tau fibrillization, a major feature in Alzheimer’s disease (AD) pathogenesis, in an in vitro assay [79].
In Type II diabetes, pancreatic amyloid deposits of amylin are apparently cytotoxic to β-cells. The main
phenolic component of EVOO, oleuropein aglycone, when present during the aggregation of amylin,
consistently prevented its cytotoxicity to RIN-5F pancreatic β-cells. Moreover, a lack of interaction
with the cell membrane of amylin aggregates was observed when cells were grown in the presence of
oleuropein. These observations suggest that oleuropein aglycone interferes with amylin aggregation,
resulting in a different path skipping the formation of toxic prefibrillar aggregates [80]. Therefore, it is
possible that EVOO could be used to prevent or treat these aging-related diseases or aging changes
possibly due to some compound present in this food having an effect on a mechanism regulating
protein homeostasis. The relationship between EVOO and AD will be considered specifically in a later
section (see Section 8: Olive oil and Cellular Senescence).
Different compounds or extracts from EVOO have been related with an increase of some
components of the chaperones family or up-stream factors regulating them. Treatment with an
EVOO secoiridoid-rich phenolic extract markedly up-regulated the expression of the HSPA6 (Hsp70B’)
gene, which is strictly inducible with no detectable basal expression [81,82]. Indeed, HSPA6 protein
induction is a sensitive biomarker of cellular stress that appears transiently in response to heat
stress, whereas levels of HSPA1A (Hsp72), which was also induced by an EVOO secoiridoid-rich
phenolic extract, persist for days [83]. The secoiridoids also enhanced the expression of the HSPA1L
gene (Hsp70-hom or Hsp70t), which encodes a constitutively expressed, non-inducible cytosolic
protein that is highly abundant in testis [84,85], and of HSPA2 (Hsp70-2), a constitutively expressed
gene that is also expressed at high levels in testis [86]. Treatment with tyrosol expanded longevity
of several mutant strains of C. elegans and such effect has been related with the master regulator
of the heat-shock response, the transcription factor HSF-1 [87]. The importance of the activation
degree of this transcription factor for longevity and thermotolerance increase in nematodes has been
previously reported [88,89]. In mammalian cells, deacetylation of HSF-1 by SIRT1 potentiates the
transactivation of heat-shock genes such as Hsp70, whereas down-regulation of SIRT1 attenuates
the heat-shock response [90]. SIRT1 interacts with FOXO1, an anti-aging transcription factor which
is negatively regulated by Akt [91,92]. OO could have effect on proteostasis by means of SIRT1
activation. In skeletal muscle cells, treatment with oleic acid (OA) increased intracellular levels of
cyclic adenosine monophosphate (cAMP) that turned on protein kinase A activity. This resulted in
SIRT1 phosphorylation at Ser-434 and elevation of its catalytic deacetylase activity [93].
In relation to proteasome, continuous treatment with oleuropein has shown to increase
proteasome-mediated degradation rates in early passage human embryonic fibroblasts cultures,
possibly through conformational changes of the proteasome. As consequence, a decrease in the amount
of oxidized proteins was also observed. In addition, oleuropein-treated cells retained proteasome
function during replicative senescence and cultures exhibited a delay in the appearance of senescence
morphology and their life span was extended by approximately 15% [94] which confirmed the
importance of proteasome function in aging processes. Furthermore, this indicates that certain extracts
from olive leaf may be beneficial with respect to proteasome activity. The possibility exists that
oleuropein derivatives found in greater concentration in EVOO might exert similar effects, which
remains for further investigation. Indeed, there are more compounds shown to influence expression of
factors implicated in cell signaling pathways that contain components of the proteasome-ubiquitin
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system. Regarding autophagy, it has been reported that EVOO feeding increased mRNA levels of the
authophagy marker LC3 with respect to other dietary fat sources (SO and fish oil) in 24 months old rat
gums. In the same study, levels of mRNA were also measured in rats aged 6 months, but LC3 change
was only clearly noted in old animals [95]. In turn, dietary supplementation with EVOO decreased
mRNAs levels of the autophagy markers LC3 and Beclin1 in muscle of a transgenic mouse model of
amyotrophic lateral sclerosis, among other effects [96]. These results are consistent with the idea that
VOO targets other processes that prevent protein damage in this tissue and, consequently, less protein
removal is needed.
Research focused on the effects of different compounds on cell signaling cascades has also
supplied interesting results concerning autophagy control. In particular, the mammalian target of
rapamycin (mTOR) have spurred extraordinary interest after the demonstration that constant or
intermittent administration of its inhibitor, rapamycin, can increase the lifespan of middle-aged
mice [97,98] and delays multiple aspects of aging in mice [99]. In most of cases, the actions of OO
compounds on mTOR-dependent signaling were accompanied by higher surveillance and stress
resistance. Part of these effects also could be caused by effects on other processes regardless of
autophagy, as many antioxidant defense systems share part of these signaling cascades [100]. Since
mTOR route is specifically involved in nutrient sensing, another well-established hallmark of aging,
the effect of OO components on the mTOR kinase will be described in the next section (see Section 6:
Olive oil and Nutrient Sensing Pathways).
The effects of fatty acids and other minor compounds from EVOO on the unfolded protein
response (UPR), a specific pathway aimed to restore proteostais in endoplasmic reticulum (ER), have
been also extensively studied. This pathway mainly operates by attenuating protein synthesis and
import to ER, and by activating a cascade of transcription factors that regulate genes encoding for ER
chaperones, components of the ER-associated protein degradation system (i.e., ubiquitin-proteasome
components), and components of the autophagy machinery [101,102]. As in other cell compartments,
unfolded or misfolded proteins can accumulate in the ER lumen, aggregate and hence become toxic
and detrimental to cell survival [101]. Facing these situations collectively referred as ER stress, cells
have evolved systems to detect, eliminate and avoid further accumulation of unfolded or misfolded
proteins. ER stress seems to occur in correlation with senescence, leading to activation of UPR [101].
Actually, some chronic diseases have been associated with apoptosis or necrosis derived from ER stress
including diabetes mellitus [103] or diabetic nephropathy [104].
Two in vitro studies have shown that, in comparison to SFA, MUFA as present in OO could
prevent or decrease apoptosis and/or necrosis derived from ER stress [103,104]. In INS-1E β-cells,
combination of oleate with palmitate prevents apoptosis and viability decrease that is otherwise
noted when cells are treated with palmitate alone. In addition, oleate also prevents the increase of
UPR marker associated to palmitate, which suggested that oleate prevent ER-stress and thus, UPR
is not needed. On the other hand, mRNA expression of the ER chaperones (Bip, Pdi, Calnexin and
Grp94) was not altered by fatty acids in this model [103]. This suggests that oleate protects INS-1E
β-cells from palmitate-induced apoptosis by the suppression of ER stress which was independent on
chaperone activation. The analysis of the data from different studies does not highlight any differences
regarding the cell type [101]. The activation of the UPR seems to occur in all types of senescence,
whatever the inducer is successive replications [105,106], oncogene activation [107], DNA-damaging
agents [107,108], or oxidative stress [105]. However, the precise signature of ER stress varies according
to the context [101]. In the same sense, analysis of SCD1 knockdown models that lead to an increase of
SFA and a decrease of MUFA have been associated to several markers of UPR activation in different
cell cultures [57]. In other study carried out at a cellular level, such intervention has shown to
increase palmitate-induced ER stress and apoptosis, whereas overexpression of SCD2 that increased
desaturation of palmitate to MUFA, attenuated palmitate-induced ER stress and apoptosis [109].
According to these findings, a decrease in membrane MUFA would induce ER stress and, as a
consequence, UPR would be activated to restore homeostasis. On the contrary, an increase of MUFA
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makes cells less susceptible to SFA-induced ER stress and apoptosis. OO has been related to an increase
of MUFA membrane content [58]. Thus, based on the fatty acids profile in OO, this food should decrease
accumulation of misfolded and unfolded proteins in ER and possibly in other organelles, although
the mechanisms under this effect need to be explained. Similarly, there are also in vitro evidences
for effects of other minor compounds on this sense. An EVOO secoiridoid-rich extract upregulated
the transcriptional expression of the DNAJA4 and DNAJC3 genes, which encodes the ER-localized
DNAJ family of proteins [110]. The induced transcription of DNAJ genes is part of the UPR [111–114].
The ability of secoiridoids from EVOO to upregulate a set of genes involved in the ER stress response
to accumulation of unfolded proteins may appear to conflict with the demonstrated ability of these
compounds to strongly inhibit the growth of highly aggressive breast cancer cells [53,115]. However,
the UPR is the major protective and compensatory mechanism that enables cells to survive during
ER stress. Secoiridoids promote cell death-UPR branch signaling by impeding the alleviation of ER
stress [116].
6. Olive Oil and Nutrient Sensing Pathways
Aging is characterized by a deterioration of homeostatic maintenance over time, leading to a
functional decline with increased risk for disease and death. This process is metabolically characterized
by insulin resistance, changes in body composition, and physiological declines in sex steroids, growth
hormone (GH) and insulin-like growth factor-1 (IGF-1) [117]. This latter alteration is indicative of a
deregulation in a nutrient sensing route during aging, because the intracellular signaling pathway
of IGF-1 is shared with that of insulin, which informs cells of the presence of the glucose, being then
regarded as insulin/IGF-1 signaling (IIS) [1]. Genetic manipulations carried out in different animal
models as worms, flies and mice in order to down-regulate this route have resulted in extended
lifespan [118] but, paradoxically, levels of GH and IGF-1 show a decline during both normal and
premature aging [119]. This apparent paradox can be explained on the basis of a defense response
elicited by the organism in order to minimize cell growth and metabolism in a systemic damage
scene [120].
Since high levels of IGF-1 are often associated with different kinds of cancer, a defensive response
against damage may have the risk of becoming deleterious and aggravating aging. In accordance,
low peripheral IGF-1 levels are associated with increased risk of numerous pathologic conditions in
aging humans, including type 2 diabetes mellitus, cardiovascular diseases, sarcopenia, osteoporosis,
and frailty [117,121]. Many research groups have thus tried to palliate these deleterious alterations
using natural substances such as OO and its derivatives. In this way, González and colleagues [122]
first postulated the antidiabetic effect of oleuropein and HT in an animal model of alloxan-induced
diabetes mellitus. Similar studies have been performed by other groups that strongly support this
protective effect. Al-Azzawie and Alhamdani [123] used 3 months-old New Zealand male rabbits
rendered diabetic by alloxan treatment and a group of these animals were given a daily oral dose of
20 mg/kg of oleuropein for 16 weeks. Blood glucose levels were decreased in oleuropein-treated group
in comparison with the diabetic controls. An increase in oxidative stress was shown in all diabetic
rabbits but was decreased significantly by oleuropein after 16 weeks of treatment. In accordance,
enzymatic and non-enzymatic antioxidants were diminished after diabetes induction, but oleuropein
treatment reverted this effect, supporting that oleuropein attenuated oxidative stress and enhanced
body´s own antioxidant defenses.
Hamden and partners [124] tested the hypoglucemic and antioxidant effects of purified HT and
WW-PE, both in alloxan-induced diabetic rats treated for two months and through in vitro models.
Phenolics were extracted from olive mill waste to separate two fractions: one of them enriched in
monomeric phenolics (F1) and the other one enriched in oligomeric and polymeric phenolics (F2).
Glucose levels were diminished with all the treatments whereas hepatic glycogen levels were increased
with respect the diabetic group. An improvement of antioxidant defense and a decrease in hepatic
and renal index of toxicity were observed in the presence of the OO phenolics in comparison with
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the diabetic non supplemented group. The histological analyses revealed the reduction of fatty cysts
in liver, the decrease of fatty infiltration in kidney, and the improvement of vascular degenerative
damage and number of β-cells in pancreas, being these observations indicative of tissue protection
against deleterious diabetic alterations. In vitro assays were carried out in parallel in perfused pancreas
of non-diabetic rats with different concentrations of glucose plus F1, F2 or HT treatment. Of note,
when pancreatic tissue was incubated with high levels of glucose combined with monomeric phenols
or HT, the organ increased insulin secretion, which was otherwise repressed when maintained with
high-glucose without additional treatment. Following a similar approach, another research group
tested the antidiabetic and antioxidant activity of oleuropein and HT at 8 and 16 mg/kg of body
weight in alloxan-induced diabetic Wistar rats [125]. Results indicated that polyphenols administration
significantly decreased blood glucose and increased hepatic glycogen levels. As reported previously,
polyphenols attenuated oxidative stress and restored antioxidant defense systems that had been
down-regulated in diabetic rats. In addition, these beneficial effects followed a dose dependent
response, with the highest concentrations of polyphenols showing the most prominent effects.
More recently, de Bock and collaborators carried out a 30-week randomized, double-blinded,
placebo controlled, crossover trial [126] in order to test the effects of supplementation with an olive leaf
extract (OLE) in middle-aged overweight men, who are more prone to be insulin resistant. Participants
received capsules with OLE or placebo for 12 weeks, and they changed the treatment after 6 weeks
of washout period. Interestingly, OLE supplementation improved insulin sensitivity by 15% and
the pancreatic β-cells function by 28%. This is consistent with the decreased levels of glucose and
insulin reached in blood. Higher levels of interleukin-6 and IGFBP-1 and -2 were observed, while
liver function, lipid profile and carotid intima media thickness did not show any changes among OLE
vs. placebo participants. Of note, this study demonstrated that two aspects of glucose regulation,
pancreatic β-cell function and insulin sensitivity, were improved in just 12 weeks of treatment.
Besides the IIS, changes in other nutrient-sensing systems are also associated with aging process.
One of best characterized systems is the mTOR kinase pathway, which plays a role in sensing high
amino acid concentrations in the organism [1]. Genetic down-regulation of one of the complexes which
constitute the mTOR kinase, mTORC1, extends longevity in yeast, worms and flies [127]. Studies
carried out by Harrison et al. [128] in mice using rapamycin, a well-known inhibitor of mTOR, have
shown extended longevity and are considered as the most robust chemical intervention to increase
lifespan in mammals [98]. Conversely, the abnormal activation of this serine/threonine kinase is
associated with a decrease in lifespan and, furthermore, is frequently observed in diseases associated
with aging, such as cancer [128,129], Alzheimer´s disease [130,131] and diabetes [132].
Several research groups have tested different kind of substances able to inhibit mTOR kinase,
considered as a good target for the treatment of cancer [133]. Evidences from independent
studies carried out with cell cultures have indicated that compounds contained in EVOO could
target differentially mTOR signaling cascades. On the one hand, HT was shown to activate the
mTOR/p70S6-kinase pathways in cultured human retinal pigment epithelial cells from the ARPE-19
cell line [100], and a gene expression study reported that OA increased mTOR pathway genes
expression in preadipocytes cultures [134]. On the other hand, oleocanthal, which exhibits potent
anticancer and neuroprotective activities, inhibited the enzymatic activity of mTOR in other in vitro
assay, and the proposal was made that beneficial activity of oleocanthal might be due, at least in part,
to mTOR inhibition [135]. Inhibitory effects on mTOR activity by different concentrations of oleocanthal
were clearly observed, which led to antiproliferative effects in MCF-7, T47D and MDA-MB-231 breast
cancer cell lines, with the latter cells being the most affected. However poor antiproliferative effects
were shown in colorectal (Caco-2) and cervical (HeLa) cancer cell lines. This could be due to the fact
that mTOR is highly expressed in breast cancer cell lines. In addition, analyses of HGF-induced mTOR
phosphorylation were carried out in MDA-MB-231 cells, either in the absence or in the presence of
oleocanthal, and the results indicated that this secoiridoid was able to suppress mTOR phosphorylation
by more than 60% without altering its total levels. In sum, these evidences strongly support the idea
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that OO, and particularly oleocanthal, can regulate the altered levels of mTOR activity in order to
protect the organism against diseases as cancer.
7. Mitochondrial Dysfunction
The free radical theory of aging proposed by Harman [136] is based on the accumulation of
oxidative damage in cells and tissues over time and its contribution to the decline of physiologic
function with age. Although multiple data support an important role for ROS in aging, developments
of the last years have led to a re-evaluation of this theory [1,137]. Leaving aside their deleterious role
in aging, it is clear that ROS contribute in triggering proliferative and survival pathways in response to
physiological signals and stress conditions [138]. Both evidences could be harmonized if we take into
account a dual role for ROS: first, as activators of compensatory homeostatic responses which increase
during aging in order to maintain survival and second, as factors that aggravate aging-associated
damage when their levels reach a certain threshold [137]. Related with this second role, mitochondria
have been proposed as an important link between oxidative damage caused by ROS and lack of normal
function. The electron transport chain located in its inner membrane (METC) metabolizes the majority
of the total oxygen taken by cells, and this organelle is thus exposed to by-products as superoxide anion
radicals or hydrogen peroxide which are potential sources of intracellular damage. This fact makes the
mitochondria a major target of oxidative damage which can lead to reduced energy production and a
compromised cell function [10].
Double bonds of membrane fatty acids are particularly sensitive to oxidative attack, which
restricts the normal ability of molecules to diffuse thus modifying membrane fluidity and finally
affecting the their normal function [10]. It is well known that the predominant fat source of the diet
influences biochemical parameters of mitochondrial membranes [139] because these organelles adapt
fatty-acid composition profile and electron-transport systems in relation to dietary fat. In that sense,
compared with a saturated or a monounsaturated dietary fat source, a polyunsaturated fat source leads
to membranes that are more prone to oxidation [140]. For this reason, several groups have focused
their research on the potential protective role of OO during aging.
Quiles and colleagues carried out a study in order to assess how the electron-transport components
are affected in several tissues by feeding Wistar rats throughout their lifespan with two different dietary
fat sources: SO (enriched in n-6 PUFA) and OO (enriched in n-9 MUFA) [141]. Mitochondrial-lipid
profile, concentration of coenzyme Q (CoQ), cytochrome b and complex IV (cytochrome c-oxidase)
activity and turnover were analyzed in liver (mitotic tissue), heart and skeletal muscle (post-mitotic
tissues) from rats fed experimental diets for 6 or 24 months. The most profound effects of age were
found in postmitotic tissues, which exhibited an overall increase in CoQ and cytochrome b together
with a decrease in the activity and turnover of complex IV. In another complementary study [142],
the mitochondrial fatty-acid profile as well as the levels of mitochondrial hydroperoxides, CoQ,
α-tocopherol, and catalase activity were measured in liver, heart and skeletal muscle from Wistar
rats fed diets containing the same fat sources (i.e., SO vs. OO) for 6, 12, 18 or 24 months and a lipid
source-dependent adaptation of mitochondrial fatty-acid profile was clearly observed. Animals fed on
a diet containing OO showed the highest amount of MUFA in their mitochondrial membranes, while
animals fed on a diet containing SO displayed the highest amount of n-6 PUFA and these changes were
in accordance with levels of oxidative damage. Among the three tissues studied, liver showed the
lowest amount of hydroperoxides. Heart and skeletal muscle hydroperoxides increased with aging in
both dietary groups, although animals fed with OO showed lower hydroperoxides than those fed with
SO at all ages. These observations indicate that an OO-containing diet leads to less polyunsaturated
membranes, resulting in the attenuation of aging-related increase of lipid peroxidation in post-mitotic
tissues, the most relevant tissues in aging [143].
Interestingly, levels of several antioxidant molecules changed in a differential way depending on
the tissue regenerative capacity. In this way, concentration of α-tocopherol decreased in aging liver in
both dietary groups, but increased in heart and skeletal muscle. CoQ levels followed a similar pattern,
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being higher in post mitotic tissues. This could be interpreted on the basis of a greater necessity to
accumulate these antioxidants in tissues that could elicit a more intensive response against oxidative
damage [144]. An increase in catalase activity is associated with greater resistance against oxidative
damage, and this seems to be crucial in overall antioxidant enzymatic defense with respect to the
lifespan [145,146]. Thus, in liver, this activity was increased with aging in rats fed the OO-containing
diet, but continued unchanged in animals fed the SO-containing diet. In heart, although both dietary
groups showed an increment in catalase activity with aging, the increase was higher in the OO group.
However, in skeletal muscle catalase activity decreased with aging in both dietary groups.
Taken together, these previous studies suggest that regenerative capacity is a plausible factor
to explain how dietary lipids can modulate aging in different tissues. In accordance with this
interpretation, the mitochondria suffer oxidative alterations and damage with aging [143,145] and
these alterations can deteriorate mitochondrial structure and function depending on the tissue capacity
to repair or to remove cell damage. Regenerative tissues, as it is the case of liver, would be able to
buffer this damage, as suggested by the lack of cytochrome oxidase activity loss in liver. However,
postmitotic tissues, as heart and skeletal muscle, are not capable to remove damaged cells leading
to decreased cytochrome oxidase activity which could produce an uncoupling of the METC and,
subsequently, an increase in free radical production [142]. Interestingly, another study carried out with
skeletal muscle of old rats fed an OO-containing diet for 6 weeks demonstrated that the aging-related
loss of METC enzyme activities, particularly complex I (NADH-CoQ oxidoreductase) and complex
IV (cytochrome c-oxidase), could be restored by this edible oil to reach the activity levels of young
animals [147].
Overall, these results highlight the important role played by dietary lipid sources in the
modification of mitochondrial membrane profile in order to generate a more “safe environment”
against the oxidative damage and lack of function associated to aging, with the MUFA-rich OO being
an optimal lipid source to perform this beneficial effect.
8. Olive Oil and Cellular Senescence
In 2012 a meta-analysis of more than 300 genome wide association studies (GWAS) identified
the INK4a/ARF locus as the genomic locus that is genetically linked to the highest number of
age-associated pathologies, including several types of cardiovascular diseases, diabetes, glaucoma,
and AD [1,148]. This last disease is a neurodegenerative pathology that affects about 30 million
people worldwide [149]. Several epidemiological studies indicate that the prevalence of AD and
cognitive decline is low among the Mediterranean area populations compared with other geographical
regions of the world [150–152]. Since phenolic constituents of EVOO as oleocanthal, oleuropein or HT
have shown antioxidant and anti-inflammatory effects [153–155], many research groups are focusing
their studies in elucidating the molecular mechanisms underlying the prevention or amelioration of
neurodegenerative diseases by this edible oil [155,156].
Although a complex disease, two well-defined phenomena are recognized in AD: the
amyloid-related neuropathological alterations in the brain, due to accumulation and deposition
of amyloid-β (Aβ) peptide [157] derived from proteolysis of Aβ precursor protein (APP) [158], and
the tau-related neuropathological alterations which results in intracellular insoluble neurofibrillary
tangles [159]. Two principal processing APP pathways have been identified: the amyloidogenic route
which leads to Aβ generation and whose molecular marker is sAPPβ, and the non-amyloidogenic
route which prevents the Aβ generation whose indicator is sAPPα [160,161]. On the other hand,
tau is a protein involved in the stabilization of the microtubules by direct interaction with a
microtubule-binding domain (MBD), working as a modifier of the cytoskeleton plasticity [162,163].
In brain from AD patients this protein is hyper-phosphorylated and then, its binding to microtubules
is inhibited [159,164]. Under these conditions, tau dissociates from axonal microtubules and
aggregates itself in an abnormal way to create insoluble paired helical filaments implicated in
neurodegeneration [165].
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Oleocanthal has been suggested to reduce the polymerization of tau protein through a covalent
mechanism [166,167]. Monti and collaborators [168] studied the recognition process and the reaction
profile between this phenolic compound and the wild-type tau protein, tau-441. Their results
showed that the interaction between them was covalent and nonspecific. This interaction induced
a conformational rearrangement of the protein due to a fast transition of the tau-441 secondary
structure to random coil to α-helix. This reorganization could explain the antifibrillogenic effect of
oleocanthal and at least the down-regulation of the pathological phosphorylation of tau. In 2013,
Abuznait and colleagues [169] reported one study focused on the role of oleocanthal in both in vitro
and in vivo models of neurodegeneration. BEnd3 cells, a mouse brain endothelial line, were treated
with different concentrations of oleocanthal ranging from 0.5 to 50 µM. On the other hand, the in vivo
model consisted in C57BL/6 wild-type mice treated with oleocanthal (10 mg/kg) during 2 weeks.
The accumulation of Aβ and its clearance from the brain facilitated by two major transport proteins:
P-glycoprotein (P-gp) and low density lipoprotein receptor-related protein-1 (LRP1) at the blood-brain
barrier were analyzed. The accumulation of Aβ in these cells were studied by uptake assays using
a radio-labeled peptide 125I-Aβ40, which has been implicated in the pathogenesis of AD [161]. P-gp
limits the entry of 125I-Aβ40 due to its efflux function whereas LRP1 enhances the cellular uptake of
125I-Aβ40. In addition, the potential modifications in Aβ degradation were also studied by analyzing
the levels of two enzymes implicated in the process: insulin degrading enzyme (IDE) and neprilysin
(NEP). In vitro results showed a significant increase of both transport proteins, P-gp and LRP1, in the
presence of oleocanthal when compared to control untreated cells. However, specific roles for P-gp
and LRP1 and their up-regulation in the presence of oleocanthal were recognized. Function of P-gp
was enhanced in the presence of oleocanthal because cellular uptake of 125I-Aβ40 was significantly
increased in the presence of the P-gp inhibitor verapamil (100 µM). In contrast, treatment of cells with
the LRP1 inhibitor RAP (1 µM) in the presence of oleocanthal slightly decreased the uptake, although
to a lower extent than in control cells, suggesting that oleocanthal might induce an unknown uptake
mechanism that is independent of LRP1 and not inhibited by RAP.
The Aβ clearance from the brain can proceed through both saturable and nonsaturable routes.
The saturable pathway involves degradation (via IDE and NEP) and efflux (via P-gp and LRP1). The
brain efflux index (BEI%) method was used to determine 125I-Aβ40 clearance through the saturable
pathway. In the presence of oleocanthal, the removal process was stimulated. This improvement
was specifically enhanced by an increment in P-gp and LRP1, because in the presence of inhibitors,
valspodar (24 ng/0.5 µL injection) and RAP (19.5 ng/0.5 µL injection) respectively, a reduction in BEI%
was observed. The percent of degraded Aβ peptides was higher in the treated group, as well as the
levels of IDE and NEP. Is sum, this study confirms that oleocanthal is able to up-regulate the expression
of proteins which lead a better clearance and degradation of pathogenic molecules involved in AD.
Very recently, the same research group has carried out another study set to investigate the
effect of consumption of a EVOO-enriched diet on amyloid- and tau-related pathological alterations
that are associated with the progression of AD and cerebral amyloid angiopathy (CAA) in TgSwDI
mice [170]. This model exhibit early-onset and robust Aβ pathology combined with cerebrovascular
changes [171]. Three experimental groups were established: a control group fed with a standard
diet, and two experimental groups fed with an EVOO-enriched diet either for 3 months beginning
at an age of 4 months (EVOO-3m) or for 6 months beginning at and age of 1 month (EVOO-6m).
The results showed that Aβ burden was lower in the EVOO-fed groups in comparison with control
animals. Both treatments reduced the total Aβ40 and Aβ42 levels, as well as Aβ plaques observed in the
hippocampus of mice. In addition, Aβ colocalization with collagen–IV (a marker of microvessels) in the
hippocampus, revealed a significant reduction in the percentage of Aβ-immunoreactive microvessels
in EVOO-6m mice, while in the EVOO-3m group only a trend towards a diminution was observed.
The 125I-Aβ40 clearance in brain was improved in both EVOO-fed groups due in part to enhanced
removal of Aβ across the blood-brain barrier, and P-gp and LRP-1 levels were also up-regulated.
Another mechanism for Aβ clearance in the brain is the ApoE- dependent pathway [172,173] whose
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effectors are ABCA1 and ApoE. An increase in the levels of both proteins was observed in both treated
groups. In addition, ligand-activated nuclear receptors, as PPARγ and LXRs which act inducing
ABCA1 and ApoE, were studied. Levels of both proteins increased in EVOO-6m, while only PPARγ
was augmented in EVOO-3m. Besides the improved clearance of Aβ, the APP process was studied
by analyzing the levels of sAPPα and sAPPβ. sAPPα, a non amyloidogenic marker, was increased
while sAPPβ, the amyloidogenic peptide, was diminished only in the EVOO-6m group. Finally,
tau expression and phosphorylation were altered in EVOO-6m mice brains. Total tau, as well as,
phosphorylated Ser214 and Thr212 isoforms, showed a significant decrease. In line with the results
observed for all the biochemical parameters studied in EVOO-6m group, a significant improvement in
hippocampus-dependent behavioral test was also observed. These animals burrowed more food pellets
and got a high score in nest construction compared to control group and EVOO-3m. In conclusion this
study confirms that a diet enriched with EVOO is able to palliate pathogenic aspects of this disease
working through different molecular targets.
Using the same in vivo AD model, TgSwDI mice, Qosa et al. studied the effect of a 4 weeks
treatment with oleocanthal through the AD pathological hallmarks [174]. A reduction in total Aβ levels
and in Aβ plaques were noted in oleocanthal-treated mice compared to normal saline treated group
(control). In addition, immunohistochemical analyses revealed a decrease in Aβ-immunoreactive
microvessels among treated animals. The APP process was not altered in the presence of the treatment.
The Aβ clearance across the BBB was improved with oleocanthal, and consequently, levels of P-gp
and LRP-1 were significantly higher. The ApoE-dependent clearance pathway was up-regulated with
the treatment, because ABCA1, ApoE and PPARγ showed an increase compared with the control
group. Considering tau-pathology, oleocanthal did not modify total levels of tau or its phosphorylation
state, which could be due to the short duration of the treatment. In addition, dysfunctional astrocytes
have been recognized in AD patient’s brains. Aβ deposition can activate astrocytes in an abnormal
manner to acquire a reactive phenotype and secrete cytokines and proinflammatory signals that
are neurotoxic [175–177]. In the presence of oleocanthal, the levels of glial fibrillary acidic protein
(GFAP), a marker of astrocyte inflammatory activation, was decreased as well as the levels of the
interleukin-1β (IL-1β).
In order to evaluate if the beneficial effect of oleocanthal observed in TgSwDI mice could be also
extended to humans, a series of experiments were performed in two human cell lines: hCMEC/D3, BBB
endothelial cells, and SH-SY5Y-APP, neuronal cells which secrete Aβ. Using different concentrations
of oleocanthal (0, 1, 5, 10 µM) during 72 h, an improvement in the basolateral transport of Aβ in
SH-SY5Y-APP cells was observed, as well as, an increase in P-gp and LRP1 expression in hCMEC/D3
cells. Collectively the results of this study, both in mice and human cell lines, evidence that this
polyphenol play a beneficial role in AD via targeting multiple pathological aspect of this disease. Taken
together, all these studies confirm that VOO and its phenolic components are able to successfully
prevent and palliate different pathogenic aspects in AD.
9. Effects of Olive Oil on Stem Cell Exhaustion
The decline in the regenerative potential of tissues is one of the most obvious characteristics in
aging [1]. In the same way, a similar functional attrition of stem cells can be found in all adult stem cell
compartments, like bone [178].
In old adults, the loss of balance between osteoblastogenesis and adipogenesis in bone marrow cell
differentiation (with adopogenesis being predominant over osteoclastogenesis) linked to an increased
level of osteoclastogenesis is a key mechanism in osteoporosis [179]. Osteoblasts and adipocytes
derive from a common multipotential mesenchymal stem cell (MSC) progenitor. During aging, several
agents including drugs, oxidative stress, hormones, metabolites, etc. can influence pluripotent MSC
differentiation resulting in an age-related bone loss [180]. Santiago-Mora and colleagues have studied
the effects of oleuropein on osteoblastogenesis and adipogenesis in MSCs from human bone marrow.
Their results showed that oleuropein stimulated osteoblastogenesis enhancing some osteogenic gene
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expression markers as well as inducing osteoblast phenotypic characteristics. Stimulation of cellular
matrix mineralization and inhibition of bone resorption were also shown. In addition, oleuropein
displayed an inhibitory effect over the most important regulators of adipogenesis, as PPARγ2, and
in the development and accumulation of fat in the cells [181]. Another study has tested the effect
of apigenin, a flavonoid compound present in OO [182], in relation with bone loss in an in vitro
model. This flavone could inhibit the production of osteoclastogenic cytokines in osteoblasts, while
in osteoclasts it could inhibit bone resorption and induced apoptosis of mature cells. Moreover,
apigenin could inhibit the differentiation of preadipocytes into adipocytes in favour of osteoblastic
differentiation [183]. Taken together these results suggest that some components of OO could prevent
age-related bone loss and osteoporosis in an in vitro system.
Liu and collaborators [184] have studied the potential beneficial effects of OO in relation
with osteoporosis in vivo, both in rats and humans. The study included artificially ovariectomized
6-month-old female Sprague Dawley rats and ten patients aged 30–50 years who had undergone a
hysterectomy and had bilateral ovarian and bilateral fallopian tube excised. Rats were fed with a
diet enriched in OO during 12 weeks after surgery whereas patients were told take 50 mL of OO
once every morning. Results showed that OO could prevent bone mineral density decline in rats and
humans. In rats, OO could also lower the serum alkaline phosphatase (ALP) solubility which promotes
mineralization of matrix proteins by hydrolysis of pyrophosphate and inorganic phosphate. These
evidences point towards an important role of OO in osteoporosis prevention.
Hematopoiesis, a tightly regulated process, is also known to decline with age resulting in
diminished production of adaptive immune cells (a process named immunosenescence) and increased
incidence of anemia and myeloid malignances [185]. Hematopoiesis is maintained by a small
pool of hematopoietic stem cells (HSCs) capable of undergoing self-renewal and generating mature
progeny of all of the hematopoietic cell lineages [186]. Samet and collaborators tested oleuropein,
apigenin 7-glucoside and luteolin 7-glucoside, polyphenols present in olive leafs and in OO, in CD34+
hematopoietic progenitor cells. Their results showed that these flavones displayed a protective effect
by allowing HSCs to survive and give rise to different colonies. Furthermore, it was shown that
olive phytochemicals modulate the fate of hematopoietic stem cells by enhancing their differentiation
potential rather than their self-renewal [187].
Another studies have recognised OA as an effective molecule because it causes mesenchymal
stem cells to secrete angiogenic mediators and regulates immunomodulatory functions [188].
Jun and collaborators have tried to deepen into this mechanism by studying the effect of OA in
a skin wound-healing model [189]. Umbilical-cord-blood-derived MSCs (UCB-MSCs) were cultured
and their motility in vitro investigated. Interestingly, cells treated with OA showed a promoted
migration in a dose-response manner independently of cell proliferation. Furthermore, this effect
was also investigated in an in vivo wound-healing model by injecting UCB-MSCs into mouse
wounds. In accordance with the results obtained in vitro, the group given OA-treated UCB-MSCs
showed an increased extent of wound closure with a complete re-epithelialization compared with
the control group. Enhanced UCB-MSC motility was linked to ephrinB2, a protein required for
vascular development with a crucial role in angiogenesis, and to F-actin, which has a vital role in
cytoskeletal rearrangements. Collectively, these results support that OA is a very important promotor
of tissue regeneration.
Endothelial progenitor cells (EPCs), which circulate peripherally in blood and originate from
stem cells, play an important role in the re-endothelisation of damaged blood vessels and in the
neovascularization of ischaemic tissues [190]. Angiotensin II, one of the pathological factors of
hypertension, has the capacity to damage vascular endothelium as well as to disrupt the regenerative
function of EPCs by inducing oxidative stress. This effect can accelerate the aging process in
the cardiovascular system. Parzonko and collaborators have examined the potential protective
effect of oleuropein and oleacein in angiotensin II-induced EPC senescence [42]. It was shown that
both compounds have a protective effect on EPC exposed to angiotensin II, not only due to their
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intrinsic antioxidant properties, but also because of the stimulation of the transcription factor Nrf2
and the enhanced expression of the enzyme heme oxygenase-1 (HO-1). Nrf2 is responsible for
intracellular antioxidant enzyme induction and protects cells against apoptosis, while HO-1, apart
from transforming heme into carbon monoxide, iron and biliverdin, displays anti-inflammatory,
anti-apoptotic and antioxidative properties [191,192].
This evidence, obtained both in vivo and in vitro, have shown that there is a relationship between
stem cells and OO and its components, which seem to display a protective effect against some
aging-related malignancies.
10. Alterations of Intercellular Communication Pathways by Olive Oil
Aging also involves changes at the level of cellular communication which can be endocrine,
neuroendocrine or neuronal [1]. One of the most important intercellular communication events
is inflammation. During this process, neutrophils and monocytes are recruited from circulation,
infiltrate the tissue and undergo a maturation process with the production of inflammatory mediators
like ROS, prostaglandins (PGs), cytokines and chemokines. All these factors cooperate to achieve
healing and to restore homeostasis to the tissue [193]. However, inflammation leads to decreased
immune responses with age causing greater susceptibility to infections and a chronic inflammation
state called “inflammaging”. Various factors contribute to this state, including polymorphisms in
the promoter regions of pro-inflammatory genes, chronic stimulation of immune cells with viruses,
cellular senescence, obesity, changes in the gut microbiome as well as increased permeability from the
intestine [194].
In this context, numerous in vitro studies have pointed out OO and its polyphenols as a
source of beneficial health properties. HT exerts anti-inflammatory effects probably through the
suppression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) expression
in human monocytic (THP-1) cells activated by lipopolysaccharides (LPS) [114]. Similar results
were shown in J774 murine macrophages stimulated with LPS, where HT down-regulates iNOS
and COX-2 gene expression by preventing NF-κB, STAT-1α and IRF-1 activation mediated through
LPS-induced ROS generation [195]. Complementary studies, carried out in freshly isolated human
monocytes activated with phorbol 12-myristate 13-acetate (PMA), show that HT is able to reduce
superoxide anions as well as inhibit the accumulation of prostaglandin E2 (PGE2), an important
inflammatory mediator, in the culture medium that is probably a direct consequence of the reduced
expression of COX2. Moreover, HT increased production of tumor necrosis factor-alpha (TNFα)
by the monocytes. These results suggest that the health effects of OO phenols may be related to
their ability to modulate the production of pro-inflammatory molecules, a property common to
non-steroidal anti-inflammatory drugs [193]. However, HT is not the only compound of OO that has
anti-inflammatory properties. Some evidences have shown that the COX2 mRNA was also efficiently
inhibited by OO secoiridoids [193]. One polyphenol of this group, oleuropein aglycone, also seems to
inhibit TNFα induced matrix metalloproteinase 9 (MMP-9) in a monocyte cell line [196]. The phenolic
compound oleocanthal has been found to share the same mechanistic anti-inflammatory pathway as
the non-steroidal anti-inflammatory drug ibuprofen [153]. Moreover, the flavonoid apigenin regulates
the expression of miR-155, suggested as an immune modulatory checkpoint and a main regulator of
the key inflammatory molecule TNFα, during LPS induced inflammation in macrophages, thereby
helping to restore immune balance [197].
Atherosclerosis is an inflammatory disease closely related to endothelial dysfunction. Early stages
are characterized by the transport of LDL particles across the endothelium wall, which triggers several
endothelium responses, such as the expression of adhesion molecules and the release of cytokines,
which leads to the tethering, activation and attachment of lymphocytes and macrophages. In vitro
studies have shown that OO phenolic compounds repress the gene expression of pro-atherogenic
adhesion molecules via inactivation of NF-κB in endothelial cells [198]. Furthermore, these compounds
show a powerful ROS scavenging activity in the presence of high oxidative stress, prevent oxidative
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damage to DNA, and enhance antioxidant activity in endothelial cells [199]. Recent studies have
complemented this hypothesis by treating human umbilical vein endothelial cells (HUVEC) with
human serum obtained after the intake of high-phenol and low-phenol VOO-based breakfasts. The
treatment with serum obtained after the intake of a high-phenol VOO-based breakfast decreased the
expression of inflammatory and oxidative stress-related genes as MCP-1, a pro-inflammatory cytokine
that plays a critical role in atherosclerotic plaque formation, and reduce the oxidative stress in HUVEC.
A high-phenol VOO-based breakfast seems to modulate positively the pathophysiological mechanisms
that underlie the early atherosclerosis in the vascular endothelium by decreasing inflammation and
improving the antioxidant profile [200].
The anti-inflammatory potential of VOO and its phenolic compounds has also been investigated
in vivo. Santos-González and colleagues [201] studied how dietary oils affected the level of plasma
proteins during aging in rats using a proteomic approach. Rats were fed lifelong with two experimental
diets enriched in SO or VOO and significant changes in 16 proteins were highlighted with respect
to aging or diet. These proteins played different roles in inflammation, lipid metabolism and
transport, coagulation, platelet function and antioxidant protection. This study strongly supports
that the intake of a diet rich in VOO has greater benefits than a diet rich in SO improving and
maintaining an antioxidant status, an anti-inflammatory state and anti-atherogenic lipid profile during
aging. Moreover, benefits have been demonstrated not only for OO but also for some of its minor
constituents. Gong et al. has studied the effect of 20% HT (HT-20) on carrageenan-induced swelling and
hyperalgesia of rat paw. Carrageenan-induced hindpaw inflammation is a neutrophil-mediated acute
inflammatory response that produces hindpaw swelling, erythema and localized hyperthermia [202].
Interestingly, HT-20 inhibits acute inflammation and hyperalgesia (inflammatory pain) induced by
carrageenan in rats. In addition, HT-20 appears to decrease IL-1 and TNFα, and no increase of
the anti-inflammatory cytokine mRNA expression of IL-10 was observed [203]. Another study has
reported the beneficial effect of EVOO on dextran sulfate sodium (DSS)-induced chronic colitis in mice
by cytokine modulation and COX-2 and iNOS reduction via downregulation of p38 MAPK. A higher
significant reduction in iNOS in HT-enriched EVOO diet compared with EVOO alone was observed as
well [204]. Complementary results also suggest that the supplementation of refined OO with HT may
be advantageous in rheumatoid arthritis with significant impact not only on chronic inflammation but
also on acute inflammatory processes in rats [205]. Also, a celery-based apigenin-rich diet regulate the
expression of miR-155 during LPS-induced inflammation in vivo [197].
Injuries also activate the local and systemic immune response with inflammatory reaction and
complex interactions among cells and soluble mediators [206]. The role of n-9 MUFA present in OO
in the modulation of the inflammatory and immune responses in the healing of cutaneous wounds
was evaluated. Mice lesions treated with n-9 MUFA displayed a high level of IL-17 accompanied
by increased collagen III expression at the final inflammatory phase of tissue repair, suggesting
that the presence of this cytokine may be involved in accelerated wound healing. Elevated IL-10
and diminished COX2 gene expression were also found in n-9 MUFA treated wounds. IL-10 has
been classically described as an important modulator of the inflammatory process, inhibiting several
pro-inflammatory pathways [207]. Its production may balance the effects of IL-17, thus modulating
the inflammatory process in n-9 MUFA treated wounds and contributing for the accelerated wound
healing [188].
Some evidences showing the protective effect of OO have been also found directly in humans
where cardiovascular diseases are clinical features of advanced atherosclerosis, and are often associated
with aging [208]. It has been suggested that consumption of VOO during 3 weeks leads to a decrease
of IL6 and C-reactive protein (CRP) higher than the decrease observed after refined OO consumption
in patients with stable coronary heart disease, indicating an important role of minor antioxidant
compounds of EVOO [209]. Moreover, EVOO consumption increased the anti-inflammatory effect
of HDL and reduced the age-related decrease in anti-atherogenic activity [210]. Similar results also
suggest a protective postprandial effect in healthy and hypertriacylcerolaemic subjects by reducing
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levels of adhesion molecules of the Ig superfamily [211]. Camargo et al. have concluded that
intake of a polyphenol-rich VOO-based breakfast is able to repress in vivo expression of several
pro-inflammatory genes, thereby switching activity of peripheral blood mononuclear cells to a
less deleterious inflammatory profile [212]. Complementarily, Konstantinidou et al. reported that
EVOO containing 328 mg/kg of phenolics in a 3-month intervention played a significant role in the
downregulation of inflammatory genes implicated in atherosclerosis compared with an oil containing
55 mg/kg [213]. It was thus suggested that the benefits associated with a Mediterranean-type diet and
OO polyphenol consumption on coronary heart disease risk can be mediated through changes in the
expression of atherosclerosis-related genes.
11. Concluding Remarks and Perspectives
Cumulative evidence using cellular, animal and human models supports that dietary OO, and
particularly VOO and EVOO, produce a series of healthy effects in many processes related with aging.
Beneficial effects of OO consumption can be explained both on the basis of the its high MUFA content
and on the healthy properties of its minor bioactive compounds. Effects of OO components on cells
can be direct, for instance due to their intrinsic antioxidant properties, or indirect, mostly due to their
ability to modulate gene expression. Among the minor constituents of VOO and EVOO contained
in its non-saponifiable fraction, secoiridoids emerge by their capacity to modulate many pathways
that are relevant for the aging process. Since this fraction is almost lost by refining procedures, EVOO
should represent the best choice for healthy aging [214]. To this regards, it is very important to take
into consideration that the amount of olive phenolics varies greatly, not only among different olive
varieties, but also depending on the ripening phase, with an increase of some phenolics like HT and
tyrosol and a decrease of others such as oleuropein aglycone with maturation [215–218]. Protection of
mitochondrial and nuclear DNA against oxidative stress-induced damage can be exerted directly by
the antioxidants contained in OO, with VOO polyphenols being particularly active. This action can be
further increased by virtue of their ability to sustain endogenous antioxidant systems (both enzymatic
and nonenzymatic) resulting in the attenuation of aging-related increase of lipid peroxidation in
post-mitotic tissues, the most relevant tissues in aging, and contributing to the maintenance of genomic
stability, particularly in the case of mitochondrial DNA. Although a positive relationship of leukocyte
telomere length and Mediterrranean diet adherence has been also reported, studies directly evaluating
the effects of OO intake on leukocyte telomere length and their effects on telomerase activity are
absent, which warrants further investigation. Ethnicity may be also an important factor that must be
taken into account to understand the role of Mediterrranean diet (and possibly of OO) on telomere
length. OO may induce epigenetic changes both by means of its MUFA content and by its phenolic
compounds. The effect of EVOO on proteostasis is apparently age and tissue-specific. Secoiridoids
enhance the expression of chaperones and are important modulators of proteostasis and nutrient
sensing alterations with aging. Research carried out by different groups with different models support
the potential role that OO and particularly some of its phenolic compounds play in preventing and
palliating some aging-associated diseases as diabetes. Of note, oleuropein produced antidiabetic
effects in animal and cellular models and, interestingly, an olive leaf extract reproduced these effects in
middle-aged overweight men, who are more prone to be insulin resistant. However, it is important
to note that compounds contained in EVOO could target differentially mTOR signaling, one of the
most important regulator of nutrient sensing which inhibition is associated with enhanced longevity.
In this way, whereas both oleic acid and HT seem to activate mTOR signaling, oleocanthal inhibits this
pathway which may be a major contributor to the healthy actions of this compound. Mediterranean
diet is also associated with improvements of cognitive decline in aging which could be related with
healthy effects of oleocanthal as recognized in mice and human cell lines. Secoiridoids as oleuropein as
well as other olive phytochemicals and OA also appear to exert positive actions on stem cells function
and have been recognized as very important promotors of tissue regeneration both in vivo and in vitro.
Finally, inflammation is another major target of OO which can be explained by the anti-inflammatory
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action of HT and OO secoiridoids. Translation of these observations, particularly those involving
in vitro approaches (which miss the effects of phenolic metabolites) and those using extracts or purified
compounds at nonphysiological concentrations, to the actual effects of dietary OO on human aging
should be carried out with caution. In addition, when investigations have been carried out with
extracts, it is not possible to ascribe the observed effects to a particular compound [9]. In any case,
the recognition that positive effects of OO are exerted on virtually all the proposed hallmarks of aging
in both organisms and cellular models could help us to understand the molecular basis of health
improvement, reduced risk of aging-associated diseases, and increased longevity which have been
associated with consumption of a typical Mediterranean diet containing OO as the predominant fat
source. Future research on this interesting topic is clearly warranted.
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